Songwon Industrial Co Ltd

Songwon Industrial Co Ltd has a liquidity profile that is medium in risk, with a current ratio of 2.18 and cash and equivalents of 111,745 million KRW. However, the company has a negative net cash position after subtracting total debt, which is a key liquidity flag. The price-to-book ratio is 0.39, indicating that the company's market value is significantly below its book value, which may suggest undervaluation or asset impairment concerns. The company's profitability is weak, with a return on equity of 0.0031 and a return on assets of 0.002, both well below typical thresholds for healthy returns in the Diversified Chemicals industry. Operating income of 21,845 million KRW and net income of 2,337 million KRW indicate a narrow margin structure, which is a concern given the capital-intensive nature of the industry. Songwon Industrial Co Ltd's revenue is derived from industrial and performance chemicals, with no disclosed segment breakdown. The company operates in both domestic and overseas markets, but the financial data does not provide geographic revenue concentration details. This lack of transparency may obscure potential regional risks or growth opportunities. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. Capital expenditures of -31,266 million KRW suggest a reduction in investment, which may signal a strategic shift or financial constraint. The operating cash flow of 53,538 million KRW is positive but modest, which may limit the company's ability to fund expansion or innovation. The risk assessment indicates a low dilution risk, with no significant dilution sources identified in the provided data. However, the company's debt-to-equity ratio of 0.24 suggests a relatively conservative capital structure, which may limit financial flexibility. The key liquidity flag of negative net cash after debt is a red flag that requires monitoring. Recent events and filings are not detailed in the provided data, so no specific recent developments can be cited. The company's financial statements and disclosures should be reviewed for any material changes in strategy, operations, or risk exposure.